Exenatide once weekly versus placebo in P... - Cure Parkinson's

Cure Parkinson's

26,583 members27,901 posts

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Farooqji profile image
5 Replies

Does anyone know about any follow up study to the below outcome

thelancet.com/journals/lanc...

Written by
Farooqji profile image
Farooqji
To view profiles and participate in discussions please or .
Read more about...
5 Replies
Kia17 profile image
Kia17

Iqbal

I asked about Exenatide trial from my neurologist on a routine appointment last week and he said that the trial faced some financial problems and no pharmaceutical company wanted to accept the risk since they are getting enough profits with selling the drug to diabetic patients.

Farooqji profile image
Farooqji in reply toKia17

Thanks for sharing this. It's unfortunate that we are at the mercy of big pharma

Despe profile image
Despe in reply toFarooqji

It's all about PROFIT!

Buckholt profile image
Buckholt in reply toKia17

On that basis, actually finding a cure would be terrible news ans should be avoided at all costs!

M1tz1 profile image
M1tz1

Hi iqbaliqbal, this should be of concern to Ian Frizell who has been battling, unsuccessfully so far, to get his need to try Exenatide recognized.

Not what you're looking for?

You may also like...

A randomised, double-blind, placebo-controlled clinical trial of Zishenpingchan granules

Results demonstrated that Zishenpingchan granules significantly reduced the occurrence of motor...
Farooqji profile image

Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease (Exenatide-PD3)

https://clinicaltrials.gov/ct2/show/NCT04232969 Wondering if anyone on this forum has been taking...
Farooqji profile image

Mucuna Pruriens in Parkinson's disease, dosages and effects, A double-blind, randomized, controlled, crossover human study (2017)

Mucuna pruriens in Parkinson disease. A double-blind, randomized, controlled, crossover study...
Greenday profile image

Hot off the press. Randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease.

Open access Published: 28 November 2023 Abstract Nicotinamide adenine dinucleotide (NAD)...